Wednesday, 01 December 2021

WHO-sponsored Covid-19 tool 'ACT-Accelerator' has shown results: Tedros

14 August 2020 | News

"The ACT-Accelerator is the only up and running global initiative that brings together all the global R&D, manufacturing, regulatory, purchasing and procurement needed, for all the tools required, to end the pandemic," says WHO Director General.

Photo Credit: WHO

Photo Credit: WHO

In April 2020, WHO launched access to COVID-19 Tools (ACT) Accelerator, as new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. The ACT-Accelerator is organized into four pillars of work: diagnostics, treatment, vaccines and health system strengthening.

The access to COVID-19 Tools (ACT) Accelerator brought together governments, scientists, businesses, civil society, and philanthropists and global health organizations (the Bill & Melinda Gates FoundationCEPIFINDGaviThe Global FundUnitaidWellcome, the WHO, the World Bank and Global Financing Facility).

On 13 August 2020, in a media briefing WHO Director-General Dr Tedros Adhanom Ghebreyesus stated that "Access to Covid-19 Tools ACT-Accelerator and started in April, has come out with Nine vaccine candidates are already being in the COVAX portfolio and going through Phase 2 or 3 trials; and this portfolio – already the broadest in the world – is constantly expanding".

He further stated, "Through the COVAX Global Vaccines Facility, countries that represent nearly 70% of the global population have signed up or expressed an interest to be part of the new initiative".

"On therapeutics, the first proven therapy for severe COVID-19, Dexamethasone, was announced in June with support from the therapeutic accelerator arm and is currently in scale-up.

On diagnostics, more than 50 tests are currently in evaluation, and new evidence has been generated around rapid antigen detection tests that could be game-changing", he added.

Mentioning ACT-Accelerator as the best economic stimulus the world can invest, Dr Tedros stated that, "The Act-Accelerator is the only global framework for ensuring the fair and equitable allocation of COVID-19 tools. But it must be financed to be successful. IMF estimates the pandemic costs the global economy $375 billion US dollars a month and predicts a cumulative loss to the global economy over two years of over $12 trillion US dollars. The world has already spent trillions dealing with the short-term consequences of the pandemic. G20 countries alone have mobilized more than $10 trillion US dollars in fiscal stimulus to treat and mitigate the consequences of the pandemic. That is already more than three and a half times as much as the world spent in the entire response to the global financial crisis. We estimate that the world will need to spend at least $100 billion US dollars on new tools. The first and most immediate need is $31.3 billion US dollars, for the ACT-Accelerator"

"The world needs multiple vaccine candidates of different types to maximize the chances of finding a winning solution. The ACT-Accelerator enables governments to spread the risk and share the reward. The best solution for everyone is a blend of development assistance and additional financing from stimulus packages to fund this effort", he added.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account